China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.
On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.
Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race

This Isn’t Your Grandparents’ UN
15:29

Why Everyone Is Talking About High Diesel Prices
17:14

US-China AI Race to Take Center Stage at Trump-Xi Meeting
16:39